by Michael Morgenstern, MD | Sep 18, 2018 | Blog, Health care, medical marijuana
On June 25th, 2018, the U.S. Food & Drug Administration (FDA) approved Epidiolex (cannabidiol, CBD) for treatment of seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome, two forms of epilepsy. Epidiolex is the first plant-based drug derived from...
by Michael Morgenstern, MD | Sep 13, 2018 | Blog, Health care, medical marijuana
This has been an incredible year for the legal cannabis industry – and not just in the United States. Canada recently made history by becoming the first industrial nation in the world to pass legislation that allows adults to purchase marijuana. On October 17th, it...
by Michael Morgenstern, MD | Sep 11, 2018 | Blog, Common Disorder, Health care, medical marijuana
Managing the symptoms of Ulcerative Colitis (UC) can help patients live a more comfortable life. Though there are many conventional treatments to try, medical marijuana may also improve the quality of life of someone suffering from the condition. In this blog post,...
by Michael Morgenstern, MD | Sep 6, 2018 | Blog, Health care, medical marijuana, Uncategorized
Though some states like New Jersey are setting their sights to expand their medical marijuana programs, there’s still a giant population without access: our furry friends. While physicians can legally recommend cannabis for patients, veterinarians are still not...
by Michael Morgenstern, MD | Sep 4, 2018 | Blog, Health care, medical marijuana
After experiencing a trauma, some people have the ability to bounce back and go about their daily lives without struggle. However, others end up developing post-traumatic stress disorder. This debilitating condition can last for years after the triggering incident....
Recent Comments